Financhill
Back

Akoya Biosciences Quote, Financials, Valuation and Earnings

Akoya Biosciences Price Quote

$2.42
-0.16 (-6.2%)
(Updated: June 27, 2024 at 2:05 PM ET)

Akoya Biosciences Key Stats

Sell
47
Akoya Biosciences (AKYA) is a Sell

Day range:
$2.30 - $2.59
52-week range:
$1.88 - $7.68
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.30
P/B ratio:
3.89%

Volume:
291.5K
Avg. volume:
545.7K
1-year change:
-61.89%
Market cap:
$127.4M
Revenue:
$96.6M
EPS:
$-1.47

How Much Does Akoya Biosciences Make?

Is Akoya Biosciences Growing As A Company?

  • What Is Akoya Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.14%
  • What Is Akoya Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Akoya Biosciences Stock Price Performance

What Is Akoya Biosciences 52-Week High & Low?

Akoya Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akoya Biosciences?

  • How Much Debt Does Akoya Biosciences Have?
    Total long term debt quarterly is $75.5M
  • How Much Cash Does Akoya Biosciences Have?
    Cash and short term investments quarterly total is $61.6M
  • What Is Akoya Biosciences’s Book Value Per Share?
    Book value per share is 0.66

Is Akoya Biosciences Cash Flow Positive?

  • What Is AKYA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$52M
  • What Is Akoya Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $56.8M
  • What Is Akoya Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$51.7M

Akoya Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    AKYA return on invested capital is -56.28%
  • What Is Akoya Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -39.74%
  • What Is AKYA Return On Equity?
    ROE is a measure of profitability and is -129.54%

Akoya Biosciences Earnings Date & Stock Price

Akoya Biosciences Competitors

Akoya Biosciences Dividend Yield

Data Unavailable

Akoya Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -19%
Revenue: -14.29% -24.43%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 6.31
Upside from Last Price: 144.67%

Major Shareholders

  • How many AKYA shares are owned by institutional investors?
    19.8M AKYA shares are owned by institutional investors
  • How many AKYA shares are owned by insiders?
    3.2M AKYA shares are owned by insiders